Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 79
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00569582 | A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome | ||
| NCT07553663 | Evaluating the Pharmacokinetics and Safety of Miricorilant | ||
| NCT05003713 | Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants | ||
| NCT03457597 | Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s | ||
| NCT03442621 | Relacorilant Food Effect Study in Healthy Subjects | ||
| NCT00936741 | An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome | ||
| NCT03877562 | The Effect of CORT118335 on Olanzapine-Induced Weight Gain | ||
| NCT06099769 | A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer | ||
| NCT06829537 | Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM) | ||
| NCT03604198 | Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome | ||
| NCT03512548 | Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its Metabolites | ||
| NCT02014337 | Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | ||
| NCT04672499 | Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants | ||
| NCT03335956 | CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) | ||
| NCT07240116 | Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects | ||
| NCT04588688 | Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency | ||
| NCT04524403 | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II) | ||
| NCT00128479 | A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression | ||
| NCT06108219 | A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH) | ||
| NCT05320146 | A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT05117489 | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT06906341 | Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers | ||
| NCT01925092 | Mifepristone in Children With Refractory Cushing's Disease | ||
| NCT02663609 | Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome | ||
| NCT04795479 | T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers | ||
| NCT05772169 | Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST) | ||
| NCT06495944 | Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants | ||
| NCT04994743 | Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants | ||
| NCT02804750 | Study to Evaluate CORT125134 in Participants With Cushing's Syndrome | ||
| NCT06094790 | A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects | ||
| NCT00455442 | A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain | ||
| NCT04672512 | Single and Multiple Ascending Dose Study of CORT125329 in Healthy Participants | ||
| NCT06094725 | A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant | ||
| NCT03259542 | Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor | ||
| NCT00796783 | A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia | ||
| NCT06947304 | Evaluation of Miricorilant on Liver Fat in Patients With MASLD | ||
| NCT06094738 | A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy Subjects | ||
| NCT02762981 | Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors | ||
| NCT05553470 | Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant | ||
| NCT05407324 | Dazucorilant in Patients With Amyotrophic Lateral Sclerosis | ||
| NCT03540836 | A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule Variants | ||
| NCT05217758 | RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma | ||
| NCT03315338 | First-in-human Study in Healthy Subjects | ||
| NCT01371565 | Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome | ||
| NCT00105105 | Mifepristone as Adjunctive Therapy in Alzheimer's Disease | ||
| NCT03674814 | Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer | ||
| NCT00208156 | A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression | ||
| NCT03508635 | CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) | ||
| NCT03258372 | Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites | ||
| NCT03878264 | Absolute Bioavailability and Metabolism Study of CORT118335 in Healthy Male Participants |
